Monday, July 13, 2026
Preview mode — showing bulk-ingested data not yet promoted to production. Hide preview

TGA / PMDA / NMPA · Asia-Pacific

ferric derisomaltose — TGA / PMDA / NMPA regulatory status

ferric derisomaltose (MONOFER) regulatory status in the Asia-Pacific is tracked from public TGA / PMDA / NMPA records and cross-linked clinical and patent datasets on NovaPharmaNews. Current status: TGA approved.

Status snapshot

Status
TGA approved
Brand
MONOFER
Mechanism
Supplement
Structured fields
6

Sponsor / originator context: A.Menarini Australia Pty Limited. Pipeline programs and exclusivity signals below are joined from ClinicalTrials.gov-linked projects and USPTO/EPO patent rows associated with this INN.

Pharmacology context used for competitive intelligence: Supplement. This page is a status aggregation for professional reference — not prescribing advice.

Regional decision snapshot — TGA: approved.

Linked evidence on this spoke: 5 published clinical programs and 0 related patent records. Use the tables below for NCT identifiers, phases, and exclusivity dates; verify against primary sources before BD or medical decisions.

Regulatory timeline

Regulator Region Status Date Source
TGA Australia approved Evidence

Linked clinical programs

Program Phase Sponsor NCT
Monofer Phase 3 Cosmo Pharmaceuticals NCT01222884
P-Monofer-CHF-02 Phase 3 Anaxis Pharma 2024-519059-28-00
iron isomaltoside(Monofer®) Phase 3 Hospital Authority NCT03565354
Ferric derisomaltose Approved Chinese Academy of NCT05971732
Ferric derisomaltose Approved Chinese Academy of NCT05991128

Related hubs

FAQ

What is the TGA / PMDA / NMPA approval status of ferric derisomaltose?

ferric derisomaltose currently shows TGA approved in our Asia-Pacific regulatory index. Confirm on the official TGA / PMDA / NMPA label or EPAR before clinical or commercial use.

Where does NovaPharmaNews get ferric derisomaltose regulatory data?

Status fields are joined from public sources (openFDA / EMA / regional agencies), ClinicalTrials.gov-linked programs, and patent registries. See /about/data-sources for attribution.

How many clinical programs are linked to ferric derisomaltose?

This spoke lists 5 published programs associated with ferric derisomaltose in our pipeline index.